ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2015

Fine Particulate Air Pollution and Systemic Autoimmune Rheumatic Disease in Two Canadian Provinces

Sasha Bernatsky1, Audrey Smargiassi2, Cheryl Barnabe3, Lawrence W. Svenson4, Allan Brand5, Marie Hudson6, Steven M. Edworthy7, Ann E. Clarke3, Paul R. Fortin8, Patrick Belisle9 and Lawrence Joseph10, 1Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Département de santé environnementale et santé au travail, Université de Montréal, Montréal, QC, Canada, 3Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 4Community Health Sciences, University of Calgary, Calgary, AB, Canada, 5Institut national de santé publique du Québec, Montreal, QC, Canada, 6Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 7The University of Calgary, Calgary, AB, Canada, 8Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada, 9Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 10McGill University, Montreal, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Environmental factors, environmental pathogens, Epidemiologic methods, scleroderma and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: To estimate the degree to which fine particulate (PM2.5) air pollution is associated with systemic autoimmune rheumatic diseases (SARDs).

Methods: We used population-based administrative data from Alberta (1993-2007) and Quebec (1989-2010). The SARD case definition was based on at least 2 physician billing claim codes, or at least 1 rheumatology billing code, or at least 1 hospitalization diagnostic code (for systemic lupus, Sjogren’s Syndrome, scleroderma, polymyositis, dermatomyositis, or undifferentiated connective tissue disease). Bayesian hierarchical latent class regression models estimated the probability that any given resident was a SARD case, given our three case definitions. Mean 2001-2006 residential exposures to ambient PM2.5 levels were assigned using satellite-derived data for Dissemination Area regions in Alberta, and Local Community ServicesCentre (CLSC) regions in Quebec (both assigned from postal code of residence). The sum of individual level probabilities provided the total cases per region in each province, according to age, sex, urban-versus-rural residence, income, and PM2.5 levels. In Alberta, we also stratified by First-Nations(FN) status, which in Alberta represents about 3% of the population (Blackfoot, Cree, Chipewyan, Dene, Sarcee, Stoney /Nakoda Sioux, and others). The hierarchical model generated odds ratio (OR) estimates for being a SARD case, based on age, sex, urban-versus-rural residence, income, and PM2.5 levels. The model accounted concurrently for these characteristics, as well as an interaction term between age and sex. The model generated Bayesian 95% credible intervals (CrI, which are similar to the non-Bayesian confidence interval) for the OR estimates.

Results: The probability of being a SARD case was higher among females versus males and for residents aged > 45 versus younger, with the highest ORs for older females. Independently, the odds of being a SARDs case increased with PM2.5 levels. In Alberta, the effect was slightly greater for FN residents. Specifically, in Alberta, when we used a continuous variable for PM2.5, the adjusted OR (interpreted as increase in SARDs per unit increase in PM25) in FN residents was 1.38 (95% CrI 1.14, 1.68) whereas in non-FN Alberta residents the adjusted OR was 1.05 (95% CrI 1.01, 1.08). In Quebec, where information on FN status (1% of the Quebec population) was not available, the adjusted OR for PM2.5 as a continuous variable, was 1.05 (95% CI 1.05, 1.06).

Conclusion: Adjusting for demographics, exposure to PM2.5 is associated with an increased risk of SARDs. Our data suggest that FN populations may be particularly vulnerable to this effect. Improving air quality across the continent appears to be an important way to reduce chronic disease burden, not only for respiratory and cardiac disease, but also systemic autoimmune rheumatic diseases.


Disclosure:

S. Bernatsky,
None;

A. Smargiassi,
None;

C. Barnabe,
None;

L. W. Svenson,
None;

A. Brand,
None;

M. Hudson,
None;

S. M. Edworthy,
None;

A. E. Clarke,
None;

P. R. Fortin,
None;

P. Belisle,
None;

L. Joseph,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fine-particulate-air-pollution-and-systemic-autoimmune-rheumatic-disease-in-two-canadian-provinces/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology